ENDRA Life Sciences Inc. — Cash Flow Charts
18 quarters of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-21.6% -$548K
$-3M
Free Cash Flow↓-69.1% -$26K
$-65K
Investing Cash Flow
$12K
Financing Cash Flow↓-4.7% -$273K
$6M
Capex↑+69.1% +$26K
$65K
Dividends Paid
$104K
Stock-Based Comp
$543K
Debt Repaid
—
D&A↑+159.4% +$33K
$54K
SBC Allocated Expense
$543K